Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)
This study is currently recruiting participants.
Verified July 2013 by Queen Mary University of London
Queen Mary University of London
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Gavin Giovannoni, Queen Mary University of London
First received: January 7, 2013
Last updated: July 12, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||August 2014|
|Estimated Primary Completion Date:||August 2014 (Final data collection date for primary outcome measure)|